natgillin/translations-raw huggingface dataset:
The line concerning metosulam in the Annex to Decision 2008/934/EC is deleted.
V Prilogi k Odločbi 2008/934/ES se črta vrstica, ki zadeva metosulam.
Member States shall adopt and publish by 31st October 2011 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 31. oktobra 2011.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing metosulam as an active substance by 1 November 2011.
Države članice v skladu z Direktivo 91/414/EGS do 1. novembra 2011 po potrebi spremenijo ali prekličejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo metosulam kot aktivno snov.
By that date they shall in particular verify that the conditions in Annex I to that Directive relating to metosulam are met, with the exception of those identified in part B of the entry concerning that active substance, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13 of that Directive.
Do navedenega datuma zlasti preverijo, ali so pogoji iz Priloge I k navedeni direktivi v zvezi z metosulamom, z izjemo tistih iz dela B besedila o navedeni aktivni snovi, izpolnjeni in ali ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni direktivi v skladu s pogoji iz člena 13 navedene direktive.
By way of derogation from paragraph 1, for each authorised plant protection product containing metosulam as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 30 April 2011 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning metosulam.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje metosulam kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo I k Direktivi 91/414/EGS najpozneje do 30. aprila 2011, v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi, in ob upoštevanju dela B besedila o metosulamu iz Priloge I k navedeni direktivi.
in the case of a product containing metosulam as the only active substance, where necessary, amend or withdraw the authorisation by 30 April 2015 at the latest; or
če sredstvo vsebuje metosulam kot edino aktivno snov, najpozneje do 30. aprila 2015 po potrebi spremenijo ali prekličejo registracijo; ali
in the case of a product containing metosulam as one of several active substances, where necessary, amend or withdraw the authorisation by 30 April 2015 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
če sredstvo vsebuje metosulam kot eno izmed več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 30. aprila 2015 ali do datuma, določenega za takšno spremembo ali preklic v ustreznih direktivah, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, pri čemer se upošteva poznejši datum.
European Food Safety Authority; Conclusion on the peer review of the pesticide risk assessment of the active substance metosulam.
Evropska agencija za varnost hrane; Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo metosulam.
CAS No: 139528-85-1
Št. CAS: 139528-85-1
CIPAC No: 707
Št. CIPAC: 707
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on metosulam, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2010 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za metosulam, in zlasti dodatkov I in II k poročilu, kot je bilo dokončno oblikovano v Stalnem odboru za prehranjevalno verigo in zdravje živali 28. oktobra 2010.
the risk to aquatic organisms;
tveganje za vodne organizme;
the risk to non-target plants in the off-field area.
tveganje za neciljne rastline na neciljnem območju.
The Member States concerned shall ensure that the applicant submits to the Commission, by 30 October 2011, further information on the specification of the active substance as manufactured.
Zadevne države članice zagotovijo, da vlagatelj Komisiji do 30. oktobra 2011 predloži dodatne informacije o aktivni snovi, kot je bila proizvedena.
The Member States concerned shall ensure that the applicant submits to the Commission, by 30 April 2013, confirmatory information as regards:
Zadevne države članice zagotovijo, da vlagatelj Komisiji do 30. aprila 2013 predloži potrdilne informacije glede:
potential pH dependence of soil adsorption, groundwater leaching and surface water exposure for metabolites M01 and M02;
morebitne odvisnosti adsorpcije tal od pH vrednosti, pronicanja v podtalnico in izpostavljenosti površinske vode, kar zadeva metabolita M01 in M02;
potential genotoxicity of one impurity.’
morebitne genotoksičnosti ene nečistoče.“
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing authorisations of plant protection products containing metosulam to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should vary, replace or withdraw, as appropriate, existing authorisations, in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti iz Direktive 91/414/EGS, ki izhajajo iz vključitve aktivne snovi v Prilogo I, je državam članicam treba omogočiti, da v šestih mesecih po vključitvi snovi pregledajo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo metosulam, da zagotovijo izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 in ustreznih pogojev iz Priloge I. Države članice v skladu z določbami Direktive 91/414/EGS obstoječe registracije po potrebi spremenijo, nadomestijo ali prekličejo.
Decision 2008/934/EC provides for the non-inclusion of metosulam and the withdrawal of authorisations for plant protection products containing that substance by 31 December 2011.
Odločba 2008/934/ES določa nevljučitev metosulama in preklic registracij fitofarmacevtskih sredstev, ki vsebujejo navedeno snov, do 31. decembra 2011.
It is necessary to delete the line concerning metosulam in the Annex to that Decision.
V Prilogi k navedeni odločbi je treba črtati vrstico, ki zadeva metosulam.
Commission Directive 2010/92/EU
Direktiva Komisije 2010/92/EU
amending Council Directive 91/414/EEC to include bromuconazole as active substance
o spremembi Direktive Sveta 91/414/EGS zaradi vključitve bromukonazola kot aktivne snovi
That list included bromuconazole.
Navedeni seznam je vključeval bromukonazol.
By Commission Decision 2008/832/EC [4] it was decided not to include bromuconazole in Annex I to Directive 91/414/EEC.
Z Odločbo Komisije 2008/832/ES [4] je bilo odločeno, da se bromukonazol ne vključi kot aktivna snov v Prilogo I k Direktivi 91/414/EGS.
Pursuant to Article 6(2) of Directive 91/414/EEC the original notifier, hereinafter ‘the applicant’, submitted a new application requesting the accelerated procedure to be applied, as provided for in Articles 14 to 19 of Commission Regulation (EC) No 33/2008 of 17 January 2008 laying down detailed rules for the application of Council Directive 91/414/EEC as regards a regular and an accelerated procedure for the assessment of active substances which were part of the programme of work referred to in Article 8(2) of that Directive but have not been included into its Annex I [5].
Prvotni prijavitelj (v nadaljnjem besedilu: vložnik) je v skladu s členom 6(2) Direktive 91/414/EGS vložil nov zahtevek za uporabo pospešenega postopka iz členov od 14 do 19 Uredbe Komisije (ES) št. 33/2008 z dne 17. januarja 2008 o podrobnih pravilih za izvajanje Direktive Sveta 91/414/EGS glede rednega in pospešenega postopka za oceno aktivnih snovi, ki so bile del programa dela iz člena 8(2) navedene direktive, vendar niso bile vključene v Prilogo I [5].
The application was submitted to Belgium, which had been designated rapporteur Member State by Regulation (EC) No 1490/2002.
Zahtevek je bil predložen Belgiji, ki je bila z Uredbo (ES) št. 1490/2002 imenovana za državo članico poročevalko.
The specification of the active substance and the supported uses are the same as those that were the subject of Decision 2008/832/EC.
Specifikacija aktivne snovi in podprte uporabe so enake kot v Odločbi 2008/832/ES.
Belgium evaluated the new information and data submitted by the applicant and prepared an additional report.
Belgija je ocenila nove informacije in podatke, ki jih je predložil vložnik, ter pripravila dodatno poročilo.
It communicated that report to the European Food Safety Authority (hereinafter ‘the Authority’) and to the Commission on 8 October 2010.
Navedeno poročilo je 8. oktobra 2010 predložila Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija) in Komisiji.
The Authority communicated the additional report to the other Member States and the applicant for comments and forwarded the comments it had received to the Commission.
Agencija je dodatno poročilo poslala v presojo drugim državam članicam in vložniku ter Komisiji posredovala prejete pripombe.
In accordance with Article 20(1) of Regulation (EC) No 33/2008 and at the request of the Commission, the additional report was peer reviewed by the Member States and the Authority.
V skladu s členom 20(1) Uredbe (ES) št. 33/2008 in na zahtevo Komisije so dodatno poročilo pregledali strokovnjaki držav članic in Agencija.
The Authority then presented its conclusion on bromuconazole to the Commission on 29 July 2010 [6].
Agencija je 29. julija 2010 [6] Komisiji predstavila svoje sklepe o bromukonazolu.
The draft assessment report, the additional report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 23 November 2010 in the format of the Commission review report for bromuconazole.
Osnutek poročila o oceni, dodatno poročilo in sklep Agencije so države članice in Komisija pregledale v okviru Stalnega odbora za prehranjevalno verigo in zdravje živali ter končno različico pripravile 23. novembra 2010 v obliki poročila Komisije o pregledu glede bromukonazola.
Those concerns were, in particular, the high risk to aquatic organisms and the lack of information available to assess the potential contamination of surface water and groundwater.
Navedeni pomisleki so zlasti visoko tveganje za vodne organizme in pomanjkanje razpoložljivih informacij za oceno morebitnega onesnaženja površinskih voda in podtalnice.
The new information submitted by the applicant allowed to assess the potential contamination of surface water and groundwater.
Nove informacije, ki jih je predložil vložnik, so omogočile oceno morebitnega onesnaženja površinskih voda in podtalnice.
The information currently available indicates that the risk of groundwater contamination is low and that the risk to aquatic organisms is acceptable.
V skladu z razpoložljivimi informacijami je tveganje onesnaženja podtalnice nizko, tveganje za vodne organizme pa sprejemljivo.
Consequently, the additional data and information provided by the applicant permit to eliminate the specific concerns that led to the non-inclusion.
Zato se na podlagi dodatnih podatkov in informacij, ki jih je predložil vložnik, lahko izločijo posebni pomisleki, ki so povzročili nevključitev.
It has appeared from the various examinations made that plant protection products containing bromuconazole may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular with regard to the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo bromukonazol, lahko pričakuje, da na splošno izpolnjujejo zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to include bromuconazole in Annex I, in order to ensure that in all Member States the authorisations of plant protection products containing this active substance may be granted in accordance with the provisions of that Directive.
Zato je primerno vključiti bromukonazol v Prilogo I, da se v vseh državah članicah v skladu z določbami navedene direktive lahko registrirajo fitofarmacevtska sredstva, ki vsebujejo to aktivno snov.
Without prejudice to that conclusion, it is appropriate to obtain confirmatory information on certain specific points.
Brez poseganja v navedeni sklep je primerno pridobiti dodatne potrditvene informacije o nekaterih posameznih točkah.
Therefore, it is appropriate to require that the applicant submit further information on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin, in addition to information regarding the long-term risk to herbivorous mammals.
Zato je primerno zahtevati, da vložnik poleg informacij glede dolgoročnega tveganja za rastlinojede sesalce predloži še nadaljnje informacije o ostankih metabolitov derivatov triazola (TDM) v primarnih posevkih, posevkih, ki sledijo v kolobarju, in proizvodih živalskega izvora.
To further refine the assessment of potential endocrine disrupting properties, it is appropriate to require that bromuconazole be subjected to further testing as soon as OECD test guidelines on endocrine disruption, or, alternatively, Community agreed test guidelines exist.
Za natančnejšo oceno lastnosti, ki lahko povzročajo motnje endokrinega sistema, je primerno zahtevati dodatne preskuse bromukonazola, takoj ko bodo na voljo smernice OECD za preskušanje učinkov na delovanje endokrinega sistema ali smernice za preskušanje, sprejete na ravni Skupnosti.
This Directive shall enter into force on 1 February 2011.
Ta direktiva začne veljati 1. februarja 2011.
OJ L 295, 4.11.2008, p. 53.
UL L 295, 4.11.2008, str. 53.
European Food Safety Authority: ‘Conclusion on the peer review of the pesticide risk assessment of the active substance bromuconazole’, EFSA Journal 2010; 8(8):1704.
Evropska agencija za varnost hrane: Sklep o strokovnem pregledu ocene tveganja pesticidov z aktivno snovjo bromukonazol. EFSA Journal 2010; 8(8):1704.
Available online: www.efsa.europa.eu/efsajournal
Na voljo na spletu: www.efsa.europa.eu/efsajournal –.
The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC:
Na koncu razpredelnice v Prilogi I k Direktivi 91/414/ES se doda naslednje besedilo:
CAS No: 116255-48-2
Št. CAS: 116255-48-2
CIPAC No: 680
Št. CIPAC: 680
1-[(2RS,4RS:2RS,4SR)-4-bromo-2-(2,4-dichlorophenyl)tetrahydrofurfuryl]-1H-1,2,4-triazole
1-[(2RS,4RS:2RS,4SR)-4-bromo-2-(2,4-dichlorophenyl) tetrahydrofurfuryl]-1H-1,2,4-triazole
1 February 2011
februarja 2011
31 January 2021
januarja 2021
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on bromuconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 23 November 2010 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepi poročila o pregledu za bromukonazol ter zlasti dodatkov I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 23. novembra 2010.
In this overall assessment, Member States shall pay particular attention to:
V tej celoviti oceni morajo biti države članice zlasti pozorne na:
operator’s safety and ensure that conditions of use prescribe the application of adequate personal protective equipment where appropriate,
varnost izvajalca tretiranja ter zagotovitev, da je v pogojih uporabe po potrebi predpisana uporaba ustrezne osebne zaščitne opreme,
protection of aquatic organisms.
zaščito vodnih organizmov.
Conditions of authorisation shall include risk mitigation measures, where appropriate, such as adequate buffer zones.
Pogoji registracije po potrebi vključujejo ukrepe za zmanjšanje tveganja, kot so ustrezni varovalni pasovi.
The Member States concerned shall ensure that the applicant presents to the Commission:
Zadevne države članice zagotovijo, da vložnik Komisiji predloži:
further information on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin,
nadaljnje informacije o ostankih metabolitov derivatov triazola (TDM) v primarnih posevkih, posevkih, ki sledijo v kolobarju, in proizvodih živalskega izvora,
information to further address the long-term risk to herbivorous mammals.
informacije za nadaljnjo obravnavo dolgoročnega tveganja za rastlinojede sesalce.
They shall ensure that the applicant at whose request bromuconazole has been included in this Annex provides such confirmatory information to the Commission by 31 January 2013 at the latest.
Države članice zagotovijo, da vložnik, ki je zahteval vključitev bromukonazola v to prilogo, te potrditvene informacije predloži Komisiji najpozneje do 31. januarja 2013.
The Member States concerned shall ensure that the applicant submits to the Commission further information addressing the potential endocrine disrupting properties of bromuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, of Community agreed test guidelines.’
Zadevne države članice zagotovijo, da vložnik Komisiji predloži dodatne informacije o lastnostih bromukonazola, ki lahko povzročajo motnje endokrinega sistema, v dveh letih po sprejetju smernic OECD za preskušanje učinkov na delovanje endokrinega sistema ali smernic za preskušanje, sprejetih na ravni Skupnosti.“
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 30 June 2011 at the latest.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 30. junija 2011.
of 4 March 2010
z dne 4. marca 2010
Having regard to the Statute of the European System of Central Banks and of the European Central Bank (hereinafter the ‘Statute of the ESCB’), and in particular Article 12.1 and Article 14.3, in conjunction with the first indent of Article 3.1, Article 18.2 and the first paragraph of Article 20 thereof,
ob upoštevanju Statuta Evropskega sistema centralnih bank in Evropske centralne banke (v nadaljevanju: Statut ESCB) ter zlasti člena 12.1 in člena 14.3 v povezavi s prvo alineo člena 3.1, členom 18.2 in prvim odstavkom člena 20 Statuta ESCB,
Achieving a single monetary policy entails defining the instruments and procedures to be used by the Eurosystem, consisting of the national central banks (NCBs) of Member States whose currency is the euro (hereinafter the ‘participating Member States’) and the European Central Bank (ECB), in order to implement such a policy in a uniform manner throughout the participating Member States.
Enotna denarna politika zahteva opredelitev instrumentov in postopkov, ki se uporabljajo v Eurosistemu, sestavljenem iz nacionalnih centralnih bank (NCB) držav članic, katerih valuta je euro (v nadaljevanju: sodelujoče države članice), in Evropske centralne banke (ECB), da bi se ta politika izvajala na enoten način v vseh sodelujočih državah članicah.
Recent developments in the markets for asset-backed securities made it necessary to amend the Eurosystem credit assessment framework (ECAF) to ensure that the Eurosystem’s requirement for high credit standards for all eligible collateral is met.
Zaradi nedavnega dogajanja na trgih kolateraliziranih vrednostnih papirjev je nastala potreba po spremembi bonitetnega okvira Eurosistema (Eurosystem Credit Assessment Framework – ECAF), da se zagotovi izpolnjevanje zahteve Eurosistema glede visokih bonitetnih standardov za vse primerno zavarovanje.
In particular, it is necessary to amend the rating requirements for asset-backed securities to be eligible for use in Eurosystem credit operations in order to comply with the requirement of Article 18.1 of the Statute of the ESCB that credit operations with credit institutions and other market participants are based on adequate collateral from a Eurosystem monetary policy perspective.
Zlasti je treba spremeniti bonitetne zahteve za primernost kolateraliziranih vrednostnih papirjev za uporabo pri kreditnih poslih Eurosistema, da bi se zagotovila skladnost s členom 18.1 Statuta ESCB, ki zahteva, da se kreditni posli s kreditnimi institucijami in drugimi udeleženci na trgu sklepajo na podlagi ustreznega zavarovanja posojil z vidika denarne politike Eurosistema.
In addition to the above, the amendments aim to make a further contribution to restoring the proper functioning of the asset-backed securities market.
Poleg zgoraj navedenega je cilj sprememb dodatno prispevati k ponovni vzpostavitvi pravilnega delovanja trga kolateraliziranih vrednostnih papirjev.
In order to implement the decision of the Governing Council of the ECB of 22 October 2009, it is necessary to amend Guideline ECB/2000/7 of 31 August 2000 on monetary policy instruments and procedures of the Eurosystem [1],
Za izvajanje sklepa Sveta ECB z dne 22. oktobra 2009 je treba spremeniti Smernico ECB/2000/7 z dne 31. avgusta 2000 o instrumentih monetarne politike in postopkih Eurosistema [1] –
Amendments to Annex I to Guideline ECB/2000/7
Spremembe Priloge I k Smernici ECB/2000/7
In Section 6.3.2, the following indent is inserted after the first indent on ‘ECAI credit assessment’:
V oddelku 6.3.2 se za prvo alineo o bonitetni oceni zunanje bonitetne institucije vstavi naslednja alinea: „—
ECAI credit assessment of asset-backed securities: For asset-backed securities issued on or after 1 March 2010, the Eurosystem requires at least two credit assessments from any accepted ECAIs for the issue.
Za kolaterializirane vrednostne papirje, izdane 1. marca 2010 ali po tem datumu, Eurosistem zahteva vsaj dve bonitetni oceni katerih koli sprejetih zunanjih bonitetnih institucij za izdajo.
To determine the eligibility of these asset-backed securities, the “second-best rule” shall be applied, which means that not only the best, but also the second-best available ECAI credit assessment must comply with the credit quality threshold for asset-backed securities.
Za ugotavljanje primernosti teh kolateraliziranih vrednostnih papirjev se uporablja ‚pravilo druge najboljše bonitetne ocene‘, ki pomeni, da mora poleg najboljše tudi druga najboljša razpoložljiva bonitetna ocena zunanje bonitetne institucije dosegati bonitetni prag za kolateralizirane vrednostne papirje.
Based on this rule, the Eurosystem requires for both credit assessments an “AAA”/“Aaa” level at issuance and a “single A” level over the life of the security in order for the securities to be eligible.
Na osnovi tega pravila Eurosistem za primernost vrednostnega papirja zahteva za obe bonitetni oceni ob izdaji raven ‚AAA‘/‚Aaa,‘ ves čas obstoja vrednostnega papirja pa raven ‚single A‘.